Welcome to our dedicated page for Federated Hermes SEC filings (Ticker: FHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Federated Hermes, Inc. (NYSE: FHI) SEC filings page provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Federated Hermes is a Pennsylvania-incorporated global active investment manager, and its filings document material events, financial results and significant agreements affecting the business.
Among the most relevant documents for FHI are its current reports on Form 8-K. Recent 8-K filings include earnings releases reporting quarterly financial and operating results, with details on revenue, operating expenses, nonoperating income, net income and earnings per share. These filings also describe how revenue is derived from money market, equity, fixed-income and alternative/private markets and multi-asset assets, and provide context on assets under management across these categories.
Other 8-Ks cover material definitive agreements and strategic transactions, such as the Sale and Purchase Agreement under which Federated Hermes agreed to acquire an 80% interest in FCP Fund Manager, L.P., a U.S. real estate investment manager. The related filing outlines the structure of the transaction, purchase price components, conditions to closing and governance arrangements, offering insight into how Federated Hermes is expanding its private markets and real estate capabilities.
Federated Hermes also uses 8-K filings to disclose leadership and governance changes, including executive succession at the Federated Advisory Companies and Federated Securities Corp., and changes in board roles. These filings provide formal notice of transitions in key management positions and board composition.
On Stock Titan, FHI filings are updated as they become available from EDGAR. AI-powered tools can help summarize lengthy documents such as earnings releases and transaction-related exhibits, highlighting key figures, asset mix information and major contractual terms. Users can review Forms 10-K and 10-Q for comprehensive annual and quarterly reporting, and Forms 8-K for event-driven updates, while AI-generated insights assist in understanding how developments in assets under management, revenue composition, expenses and strategic deals may shape Federated Hermes’ business profile over time.
Federated Hermes, Inc. and related reporting persons filed an amended Schedule 13G showing beneficial ownership of 1,437,836 shares of MGP Ingredients, Inc. common stock, representing 6.75% of the class as of the stated event date. Federated Hermes and the Voting Shares Irrevocable Trust report sole voting and dispositive power over these shares, while Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue report shared voting and dispositive power over the same amount.
The reporting persons state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MGP Ingredients. They also expressly disclaim that this filing should be construed as an admission that any of them is the beneficial owner of securities held by the managed funds.
Federated Hermes, Inc. filed Amendment No. 3 to a Schedule 13G reporting beneficial ownership of 3,395,771 shares of IDEAYA Biosciences, Inc. common stock, representing 3.87% of the class as of 12/31/2025. The same share amount and percentage are reported for the Voting Shares Irrevocable Trust, and for Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue, reflecting shared or sole voting and dispositive powers as disclosed on each cover page.
Federated Hermes, the trust, and the individual filers state that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of IDEAYA. They also declare, in accordance with Rule 13d-4, that this filing should not be construed as an admission that any of them is the beneficial owner of securities held by the managed funds, and they expressly disclaim beneficial ownership of those securities. The filing indicates ownership of 5 percent or less of IDEAYA’s common stock.
Federated Hermes, Inc. and related reporting persons filed Amendment No. 3 to a Schedule 13G disclosing their beneficial ownership in Arcturus Therapeutics Holdings Inc. common stock. They report beneficial ownership of 3,303,640 shares of common stock, representing 11.63% of the class as of the event date of 12/31/2025. Federated Hermes has sole voting and dispositive power over these shares, while the Voting Shares Irrevocable Trust and Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue report shared voting and dispositive power over the same amount. The reporting persons state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Arcturus, and they expressly disclaim beneficial ownership of securities held by managed funds.
FHI filed a Rule 144 notice covering the planned sale of 5,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $261,192.00. The filing notes that 77,537,867 shares of the issuer’s common stock were outstanding and that the approximate sale date is 12/12/2025 on the NYSE. The shares to be sold were acquired as restricted stock vesting under a registered plan in several grants between 11/18/2024 and 11/18/2025 in exchange for services rendered. During the past three months, Dolores Dudiak sold 999 common shares for gross proceeds of $47,824.53.
Federated Hermes, Inc. (FHI) vice president sells shares
A company officer reported selling 5,000 shares of Federated Hermes Class B common stock on 12/12/2025. The sale is coded as an open market or private sale and was executed at a weighted average price of $52.2384 per share. According to the footnote, the shares were sold in 44 separate transactions at prices ranging from $52.055 to $52.693 per share. After this transaction, the reporting person beneficially owns 83,223 shares of Federated Hermes Class B common stock directly.
Federated Hermes, Inc. announced a planned leadership transition in its advisory and distribution businesses. Effective April 30, 2026, named executive officer John B. Fisher, currently Vice President of Federated Hermes and President and CEO of the Federated Advisory Companies, will step back from full-time responsibilities and will no longer serve as an executive officer. He will continue to be actively involved in several major strategic initiatives as Chairman of the Federated Advisory Companies.
Paul A. Uhlman, a long-tenured executive with 35 years at the firm and currently Vice President of Federated Hermes and President, Federated Securities Corp., will become President and CEO of the Federated Advisory Companies and remain an executive officer. Bryan M. Burke, with 23 years at the company and currently National Sales Director, Strategic Solutions, and Executive Vice President, Federated Securities Corp., will become President, Federated Securities Corp., and a Vice President and executive officer of Federated Hermes. Mr. Fisher will remain on the Board during the transition but will not stand for re-election at the next Annual Meeting, when Mr. Uhlman will be recommended for nomination.
Federated Hermes, Inc. (FHI) reported an insider equity transaction by an officer serving as CEO of Federated Hermes Limited. On 11/18/2025, the reporting person acquired 9,000 shares of Class B common stock at $3.00 per share, increasing their holdings. On 11/19/2025, they sold 4,461 shares of Class B common stock at a weighted average price of $47.8474 per share, with the filing stating this sale was made to satisfy tax obligations arising from the vesting of restricted shares.
Following these transactions, the reporting person beneficially owned 161,578 shares of Class B common stock, held directly. The filing notes that the sales on 11/19/2025 occurred in 36 separate transactions within a price range of $47.64 to $48.03, and the reporting person has agreed to provide detailed breakdowns upon request.
Federated Hermes, Inc. (FHI) reported an insider share sale by a company officer. A vice president filed a Form 4 disclosing the sale of 999 shares of Class B common stock on 11/19/2025. The transaction was coded as a sale and carried out at a weighted average price of $47.8724 per share, with individual trade prices ranging from $47.69 to $48.24.
According to the filing, the shares were sold to satisfy tax obligations arising from the vesting of restricted stock. After this transaction, the reporting person beneficially owns 88,223 shares of Federated Hermes, Inc. common stock.
Federated Hermes, Inc. (FHI) reported insider activity by its Principal Accounting Officer on Form 4. On 11/18/2025, the officer acquired 2,500 shares of Class B common stock at $3.00 per share, increasing direct holdings to 58,749 shares. On 11/19/2025, the officer sold 1,249 shares of Class B common stock at a weighted average price of $47.8507 per share, leaving 57,500 shares directly owned. The sale was made to cover tax obligations from the vesting of restricted stock, and the price reflects 10 separate transactions within a disclosed price range.
Federated Hermes, Inc. (FHI) executive officer (EVP, CLO & Secretary) reported changes in personal holdings of Class B Common Stock. On 11/18/2025, the reporting person acquired 18,000 shares, and on 11/19/2025 sold 6,856 shares at a weighted average price of $47.8549. The sale was made to cover tax obligations arising from the vesting of restricted shares. After these transactions, the reporting person directly beneficially owned 217,468 shares of Class B Common Stock.